| Literature DB >> 35324690 |
Lei Xia1, Hifza Rasheed2, Michael N Routledge3,4,5, Hang Wu3, Yun Yun Gong1.
Abstract
High levels of mycotoxin contamination have been reported in various food commodities in Pakistan, however, there has been no exposure assessment study using multiple mycotoxins' biomarkers. This study aimed to simultaneously assess the exposure to the five major mycotoxins: aflatoxin B1 (AFB1), deoxynivalenol (DON), fumonisin B1 (FB1), ochratoxin A (OTA) and zearalenone (ZEN) in a Pakistani population using an integrated approach of human biomonitoring. Human urine samples (n = 292) were analyzed by a super-sensitive liquid-chromatography tandem mass spectrometry (LC-MS/MS) method. Rice and wheat were also collected and analyzed for mycotoxins by the LC-MS/MS method. Food consumption data were collected using a 24 h recall method. A high prevalence of urinary AFM1 (66%, mean ± SD 20.8 ± 41.3 pg/mL) and OTA (99%, 134.7 ± 312.0 pg/mL) were found, whilst urinary DON, FB1 and ZEN levels were low. The probable daily intake (PDI) derived from the urinary biomarkers revealed that 89% of the participants had exposure to OTA exceeding the established tolerable daily intake (TDI = 17 ng/kg bw/day). The average PDI of AFB1 for the studied population was 43 ng/kg bw/day, with rice as the main source of AFB1 exposure. In summary, exposure to AFB1 and OTA are of health concern and require further management.Entities:
Keywords: UPLC-MS/MS; biomarkers; exposure assessment; human biomonitoring; mycotoxins
Mesh:
Substances:
Year: 2022 PMID: 35324690 PMCID: PMC8950642 DOI: 10.3390/toxins14030193
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Method validation parameters for food mycotoxin analysis.
| Analyte | Calibration Range (µg/kg) | Intra-Day | Inter-Day | Matrix LOD (µg/kg) | Matrix LOQ (µg/kg) | QC ( | QC ( |
|---|---|---|---|---|---|---|---|
| AFB1 | 0.16–320 a | 4 | 3 | 0.064 | 0.16 | 9 | 89 |
| DON | 64–3200 b | 4 | 2 | 32 | 64 | 8 | 89 |
| FB1 | 1.6–320 c | 5 | 4 | 0.64 | 1.6 | 9 | 107 |
| OTA | 0.8–320 d | 5 | 3 | 0.32 | 0.8 | 14 | 90 |
| ZEN | 1.6–320 c | 4 | 4 | 0.64 | 1.6 | 9 | 90 |
LOD—Limit of detection; LOQ—Limit of quantification; QC—quality control; CV—coefficient of variance; RA—apparent recovery; the matrix LOD and LOQ are for both rice and wheat matrixes; Calibration points are as follows: a 0.16, 0.32, 0.64, 1.6, 3.2, 6.4, 16, 32, 64, 160, 320 µg/kg; b 64, 160, 320, 640, 1600, 3200 µg/kg; c 1.6, 3.2, 6.4, 16, 32, 64, 160, 320 µg/kg; d 0.8, 1.6, 3.2, 6.4, 16, 32, 64, 160, 320 µg/kg.
Method validation parameters for urinary mycotoxin biomarkers analysis.
| Analyte | Calibration Range (ng/mL) | Intra-Day | Inter-Day | Matrix | Matrix | QC ( | QC ( |
|---|---|---|---|---|---|---|---|
| AFM1 | 0.002–5 a | 5 | 4 | 0.001 | 0.002 | 10 | 104 |
| DON | 0.2–50 b | 4 | 6 | 0.1 | 0.2 | 10 | 101 |
| DOM-1 | 0.05–5 c | 4 | 3 | 0.02 | 0.05 | 11 | 92 |
| FB1 | 0.002–5 a | 4 | 4 | 0.001 | 0.002 | 13 | 111 |
| OTA | 0.002–5 a | 2 | 2 | 0.001 | 0.002 | 11 | 96 |
| ZEN | 0.02–5 d | 4 | 12 | 0.01 | 0.02 | 9 | 127 |
| α-ZEL | 0.02–5 d | 5 | 12 | 0.01 | 0.02 | 11 | 106 |
| β-ZEL | 0.02–5 d | 4 | 12 | 0.01 | 0.02 | 9 | 78 |
CV—coefficient of variance; LOD—Limit of detection; LOQ—Limit of quantification; QC—quality control. Calibration points are as follows: a 0.001, 0.002, 0.005, 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2, 5 ng/mL; b 0.1, 0.2, 0.5, 1, 2, 5, 10, 20, 50 ng/mL; c 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2, 5 ng/mL; d 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2, 5 ng/mL.
Demographic characteristics of the studied population.
| Characteristics | Chak-46 | Chak-50 | BB | BP | KA | All Villages |
|---|---|---|---|---|---|---|
|
| 101 | 74 | 35 | 23 | 59 | 292 |
| Gender *** | ||||||
| 65 (64) b | 63 (85) a | 12 (34) c | 14 (61) b | 21 (36) c | 175 (60) | |
| Age *** | ||||||
| Mean ± SD (range) | 32.1 ± 17.4 (4–75) b | 42.5 ± 17.2 (5–80) a | 36.5 ± 16.5 (9–65) a,b | 38.6 ± 16.5 (15–65) a,b | 33.2 ± 33.2 (9–80) b | 36.6 ± 17.4 (4–80) |
| Occupation | ||||||
| Farmer (including students) | 88 (87) | 68 (92) | 31 (88) | 23 (100) | 54 (92) | 264 (90) |
| Chapatti consumption (g/kg b.w./day) | ||||||
| Mean ± SD | 324 ± 118 | 403 ± 120 | 369 ± 135 | 436 ± 82 | 341 ± 117 | 362 ± 123 |
| Rice consumption (dry weight) | ||||||
| Consumption rate (%) | 50.5 | 43.2 | 31.4 | 13.0 | 46.8 | 42.5 |
| Mean ± SD | 139 ± 69 | 146 ± 58 | 101 ± 28 | 174 ± 59 | 129 ± 54 | 136 ± 61 |
Statistical significance was determined based on p values: p < 0.05, *; p < 0.01, **; p < 0.001, ***; When there was an overall significant difference observed for the demographic factors between the villages, pair-wise comparison between the villages was made and villages were assigned to different groups a, b or c, following the order group mean a > b > c (a,b means not significantly different to either group a or b); the dry weight of rice consumption was derived from 29% of the rice consumption [24] and the rice consumption rate refers to the percentage of participants’ consumed rice on the previous day; the statistics for rice consumption were calculated only for those participants who consumed rice on the previous day.
Mycotoxin concentrations for major mycotoxins found in rice and wheat samples (unit: µg/kg).
|
| ||||||
| Villages | Chak-46 ( | Chak-50 ( | BB ( | BP ( | KA ( | Total ( |
| AFB1 ** ( | ||||||
| Positive | 3 (38) | 0 (0) | 13 (76) | 9 (60) | 16 (100) | 41 (66) |
| Mean ± SD | 15.01 ± 10.31 | NA (i.e., <LOD) | 13.29 ± 19.70 | 8.49 ± 14.74 | 1.09 ± 1.40 | 7.60 ± 14.06 |
| Median (range) | 17.89 (3.57–23.58) | nd | 4.17 (0.18–71.56) | 1.24 (0.31–36.88) | 0.42 (0.17–5.26) | 1.24 (0.17–71.56) |
| DON | ||||||
| Positive | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| FB1 | ||||||
| Positive | 0 (0) | 2 (33) | 0 (0) | 0 (0) | 1 (6) | 3 (5) |
| Mean ± SD | NA | 5.47 ± 2.74 | NA | NA | NA | 4.24 ± 2.87 |
| Median (range) | nd | 5.47 (3.53–7.41) | nd | nd | 1.80 | 3.53 (1.80–7.41) |
| OTA | ||||||
| Positive | 0 (0) | 0 (0) | 0 (0) | 1 (7) | 0 (0) | 1 (2) |
| Mean ± SD | NA | NA | NA | 0.40 | NA | 0.40 |
| Median (range) | nd | nd | nd | 0.40 | nd | 0.40 |
| ZEN | ||||||
| Positive | 8 (100) | 6 (100) | 17 (100) | 15 (100) | 16 (100) | 62 (100) |
| Mean ± SD | 6.91 ± 4.16 | 6.67 ± 3.79 | 4.77 ± 2.07 | 3.90 ± 2.88 | 5.43 ± 3.42 | 5.19 ± 3.19 |
| Median (range) | 5.75 (2.99–12.61) | 6.51 (2.37–13.48) | 4.22 (1.87–9.43) | 2.65 (0.8–12.23) | 4.45 (2.29–15.00) | 4.13 (0.8–15.00) |
|
| ||||||
| Villages | Chak-46 ( | Chak-50 ( | BB ( | BP ( | KA ( | Total ( |
| AFB1 | ||||||
| Positive | 1 (3) | 2 (2) | 0 (0) | 0 (0) | 0 (0) | 3 (2) |
| Mean ± SD | 0.23 | 1.00 ± 0.83 | NA | NA | NA | 0.75 ± 0.74 |
| Median (range) | 0.23 | 1.00 (0.42–1.59) | nd | nd | nd | 0.23 (0.23–1.59) |
| DON | ||||||
| Positive | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Mean ± SD | NA | NA | NA | NA | NA | NA |
| Median (range) | Nd | nd | nd | nd | nd | nd |
| FB1 | ||||||
| Positive | 0 (0) | 1 (1) | 0 (0) | 0 (0) | 0 (0) | 1 (0.5) |
| Mean ± SD | NA | 2.72 | NA | NA | NA | 2.72 |
| Median (range) | Nd | 2.72 | nd | nd | nd | 2.72 |
| OTA | ||||||
| Positive | 2 (5) | 6 (6) | 1 (8) | 0 (0) | 1 (3) | 10 (5) |
| Mean ± SD | 0.65 ± 0.35 | 2.15 ± 1.96 | 0.40 | NA | 1.46 | 1.61 ± 1.65 |
| Median (range) | 0.65 (0.40–0.90) | 1.52 (0.40–5.17) | 0.40 | nd | 1.46 | 1.13 (0.40–5.17) |
| ZEN * ( | ||||||
| Positive | 19 (48) | 28 (29) | 1 (8) | 4 (24) | 13 (45) | 65 (33) |
| Mean ± SD | 1.10 ± 0.47 | 1.57 ± 1.27 | 0.80 | 1.28 ± 0.56 | 1.10 ± 0.48 | 1.31 ± 0.92 |
| Median (range) | 0.80 (0.80–1.96) | 1.22 (0.80–7.24) | 0.80 | 1.25 (0.80–1.81) | 0.80 (0.80–2.01) | 0.80 (0.80–7.24) |
nd: not detected, (i.e.,
Urinary mycotoxin biomarker levels in the studied population (Unit: pg/mL).
| Villages | Chak-46 | Chak-50 | BB | BP | KA | Total |
|---|---|---|---|---|---|---|
| AFM1 *** | ||||||
| Positive | 87 (86) | 36 (49) | 25 (72) | 18 (78) | 28 (48) | 193 (66) |
| Mean ± SD | 36.9 ± 58.1 a | 13.5 ± 30.1 b | 6.0 ± 6.9 b | 31.2 ± 34.6 a | 7.1 ± 15.5 b | 20.8 ± 41.3 |
| Median (range) | 17.4 (nd-420.8) | nd (nd-187.7) | 2.7 (nd-27.9) | 16.3 (nd-96.4) | nd (nd-101.6) | 5.35 (nd-420.8) |
| DON *** | ||||||
| Positive | 35 (35) | 32 (43) | 18 (51) | 11 (48) | 6 (10) | 102 (35) |
| Mean ± SD | 133.8 ± 241.3 b | 180.7 ± 417.4 a,b | 178.8 ± 184.5 a | 139.8 ± 113.1 a,b | 68.5 ± 66.8 c | 138.4 ± 266.5 |
| Median (range) | nd (nd-2249.5) | nd (nd-3488.6) | 102.6 (nd-755.0) | nd (nd-393.8) | nd (nd-416.6) | nd (nd-3490) |
| DOM-1 *** | ||||||
| Positive | 12 (12) | 28 (38) | 6 (17) | 3 (13) | 13 (22) | 61 (21) |
| Mean ± SD | 49.0 ± 132.7 b | 64.4 ± 91.8 a | 35.1 ± 66.2 b | 46.2 ± 102.3 a,b | 53.1 ± 97.5 a,b | 51.8 ± 107.0 |
| Median (range) | nd (nd-776.3) | nd (nd-380.7) | nd (nd-282.1) | nd (nd-387.7) | nd (nd-384.4) | nd (nd-776) |
| FB1 *** | ||||||
| Positive | 89 (88) | 56 (76) | 33 (94) | 20 (87) | 26 (44) | 225 (77) |
| Mean ± SD | 15.6 ± 17.2 b | 18.6 ± 30.0 b | 30.9 ± 35.2 a | 27.9 ± 45.4 b | 6.60 ± 12.8 c | 17.4 ± 26.8 |
| Median (range) | 10.5 (nd-88.8) | 10.9 (nd-170.6) | 13.6 (nd-129.6) | 16.8 (nd-225.2) | nd (nd-77.4) | 9.3 (nd-225) |
| OTA *** | ||||||
| Positive | 100 (99) | 73 (99) | 35 (100) | 23 (100) | 58 (98) | 298 (99) |
| Mean ± SD | 219.3 ± 505.4 a | 77.4 ± 84.8 b | 56.9 ± 54.4 b | 147.0 ± 162.7 a | 103.4 ± 76.6 a | 134.7 ± 312.0 |
| Median (range) | 106.1 (nd-4816.4) | 60.6 (nd-611.5) | 34.7 (1.4-210.6) | 100 (13.6-704.3) | 83.1 (nd-408.3) | 74.5 (nd-4816.4) |
| ZEN *** | ||||||
| Positive | 46 (46) | 31 (42) | 10 (29) | 9 (39) | 17 (29) | 108 (37) |
| Mean ± SD | 19.8 ± 29.9 a | 25.0 ± 79.1 a | 9.0 ± 7.5 a,b | 10.1 ± 7.4 a | 8.2 ± 9.0 b | 16.7 ± 44.1 |
| Median (range) | nd (nd-174.5) | nd (nd-673.3) | nd (nd-32.0) | nd (nd-25.9) | nd (nd-55.4) | nd (nd-673.3) |
| α-ZEL ** | ||||||
| Positive | 35 (35) | 21 (28) | 5 (14) | 7 (30) | 11 (19) | 79 (27) |
| Mean ± SD | 11.5 ± 13.3 a | 13.2 ± 21.4 a | 6.6 ± 4.4 b | 9.6 ± 8.6 a | 8.2 ± 10.6 b | 10.5 ± 14.4 |
| Median (range) | nd (nd-80.9) | nd (nd-160.8) | nd (nd-25.0) | nd (nd-33.7) | nd (nd-64.0) | nd (nd-160.8) |
| β-ZEL *** | ||||||
| Positive | 43 (43) | 34 (46) | 15 (43) | 12 (52) | 8 (14) | 111 (38) |
| Mean ± SD | 25.5 ± 43.4 a | 18.2 ± 21.8 a | 24.9 ± 36.1 a | 17.0 ± 15.8 a | 11.0 ± 18.3 b | 20.0 ± 32.0 |
| Median (range) | nd (nd-361.1) | nd (nd-111.2) | nd (nd-184.4) | 10.0 (nd-62.1) | nd (nd-87.6) | nd (nd-361.1) |
nd: not detectable (i.e.,
Figure 1(a). Distribution of the participants regarding the number of co-exposed mycotoxins by percentages. The number above the percentages illustrate the number of co-occur mycotoxin biomarkers found in the urine samples; (b). The % for the most common combination: single mycotoxin; two mycotoxins; and three mycotoxins co-exposure.
Dietary exposure estimation with urinary biomarker approach.
| Mycotoxin | Urinary Excretion Rate (%) b | Mean Biomarker Conc (Max.) (µg/L) | PDI Mean (Max.) (µg/kg bw/Day) | Established TDI (µg/kg bw/Day) c |
|---|---|---|---|---|
| AFB1 | 1.3 | 0.021 (0.421) | 0.043 (0.852) | As low as possible |
| DON a | 70 | 0.140 (3.489) | 0.006 (0.153) | 1 |
| FB1 | 0.3 | 0.017 (0.225) | 0.159 (1.741) | 2 |
| OTA | 2.5 | 0.135 (4.816) | 0.145 (5.137) | 0.017 |
| ZEN a | 9.4 | 0.017 (0.673) | 0.005 (0.214) | 0.25 |
Daily urine volumes were assumed to be 36 and 18 mL/kg/day for children (4–10 years) and adolescents (10–19 years), and 2000 mL/day for adult males and 1.6 L/day for adult females, respectively, as recommended by EFSA FEEDAP Panel, (2012). a. no data are available for the excretion rate of DOM-1, α-ZEL and β-ZEL, therefore the dietary exposure of DON and ZEN were estimated by urinary DON and ZEN, respectively; b. the references for the urinary excretion rate of the mycotoxin urinary biomarkers are as follows: AFM1, 1.3% [29]; DON, 70% [30]; FB1, 0.3% [31]; OTA, 2.5% [32]; ZEN, 9.4% [33]; c. the TDI defined by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) for DON, OTA and FB1 are used [25,26,27]; the TDI defined by the European Food Safety Authority (EFSA) for ZEN is used as reference [28].
Figure 2Geographic location of the studied cohort, reproduced from [52] with permission from Elsevier, 2022.